Form 4 filings across 2 companies. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: $0
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
All 5 filings we hold were filed within the two-business-day deadline.
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings
The 12 most recent Form 4 transactions.
| Mar 31 | APRE | Aprea Therapeutics, Inc. | PDBUY◆ | 123,915 | — | — | — | Open the original filing on SEC.gov |
| Mar 31 | APRE | Aprea Therapeutics, Inc. | PDBUY◆ | 123,915 | $0.807 | $100K | — | Open the original filing on SEC.gov |
| Jun 30, 2025 | KANT | Kineta, Inc./de | DTOISS◆ | 20,000 | — | — | — | Open the original filing on SEC.gov |
| Jun 30, 2025 | KANT | Kineta, Inc./de | DTOISS◆ | 12,500 | — | — | — | Open the original filing on SEC.gov |
| Jun 30, 2025 | KANT | Kineta, Inc./de | DTOISS | 101,891 | — | — | -100.0% | Open the original filing on SEC.gov |
| Jun 25, 2025 | KANT | Kineta, Inc./de | AGRANT | 6,000 | — | — | +6.3% | Open the original filing on SEC.gov |
| Jun 23, 2025 | KANT | Kineta, Inc./de | FTAX | 4,706 | $0.26 | $1.2K | -4.7% | Open the original filing on SEC.gov |
| Jun 23, 2025 | KANT | Kineta, Inc./de | MEXER | 12,500 | $0.611 | $7.6K | +14.2% | Open the original filing on SEC.gov |
| Jun 5, 2025 | APRE | Aprea Therapeutics, Inc. | AGRANT◆ | 4,185 | — | — | — | Open the original filing on SEC.gov |
| Jun 5, 2025 | APRE | Aprea Therapeutics, Inc. | AGRANT | 1,045 | — | — | +50.4% | Open the original filing on SEC.gov |